China SXT Pharmaceuticals, Inc.
SXTC · Pharmaceutical Preparations
Latest available SEC filing: 20-F ·
Latest disclosures
-
Latest financial period: Q1 2026
Financial facts · Filed
-
Form 20-F
SEC filing · Filed
-
Pan Xiaodong Sean: Form 3
Insider disclosure · Filed · Report period 31 Jan 2022
-
Form 3
SEC filing · Filed
-
Form 3
SEC filing · Filed
-
Form 3
SEC filing · Filed
-
Form 3
SEC filing · Filed
-
Form 3
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
Company details and SEC sources
CIK 0001723980 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- SXTC on Nasdaq
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- 178 Taidong Road North, Taizhou
- Incorporated in
- Virgin Islands, British
- Fiscal year end
- 31 March
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields